Dave Muoio

By Dave Muoio 11:09 amFebruary 19, 2018
Ann Mond Johnson will be taking over as CEO of the the American Telemedicine Association in early March, according to a statement released last week. She previously served as the CEO of Zest Health, served as board chair and advisor to ConnectedHealth, and has a history of entrepreneurship. The CEO position’s previous occupant, Jonathan Linkous, stepped down last year after 24 years at the...
By Dave Muoio 04:49 pmFebruary 15, 2018
Pharma giant Roche is set to acquire oncology EHR software firm Flatiron Health in the first half of 2018, the companies announced today in a statement. Roche will pay an additional $1.9 billion over the millions it had already invested into the company in 2016, and as a result of the deal will control all shares of Flatiron Health. “This is an important step in our personalized healthcare...
By Dave Muoio 04:05 pmFebruary 15, 2018
Insulin dose tool gains CE Mark. DreaMed Diabetes has received a CE Mark for its Type 1-focused clinical decision support (CDS) platform, Advisor Pro. The tool’s algorithms process data from a number of connected diabetes management devices to provide a personalized insulin dosing treatment plan. The software achieved similar glycemic control when compared to medical experts during pilot studies...
By Dave Muoio 01:42 pmFebruary 15, 2018
As new technologies and consumer-focused strategies continue their takeover of the healthcare industry, health systems will have to adjust their care models or be left in the dust. Rewiring an incumbent healthcare enterprise is no easy feat, however, and nearly every decision and assumption made along the way is a potential pitfall that requires an open mind. “Team-based, technology-enabled,...
By Dave Muoio 04:07 pmFebruary 14, 2018
The FDA announced yesterday that it will permit marketing of Viz.ai’s Contact, a clinical decision support (CDS) tool that analyzes CT results and highlights cases that may have experienced a stroke. The CDS application was submitted through the agency’s de novo premarket review pathway, and as such creates a new regulatory classification for similar AI-drived platforms to come. The FDA’s...
By Dave Muoio 10:55 amFebruary 14, 2018
Digital diabetes care company Glooko announced today that its Mobile Insulin Dosing System (MIDS) — an app-driven tool that recommends insulin dose adjustments using data collected directly from a patient’s blood glucose meter — has been cleared by the FDA. The MIDS module allows clinicians to create a customized treatment plan and send it to Type 2 diabetes patients directly through the company’...
By Dave Muoio 03:47 pmFebruary 13, 2018
Clarify Medical will be debuting its handheld, smartphone-connected phototherapy device later this week at the American Academy of Dermatology Annual Meeting, according to a statement. The technology powering the Home Light Therapy System received FDA 510(k) clearance last June, and is to be used in the treatment of skin diseases including psoriasis, vitiligo, and eczema. “The Clarify System...
By Dave Muoio 01:36 pmFebruary 13, 2018
Bensheim, Germany-based drug delivery system manufacturer Sanner GmbH and London, UK-based Amiko — a startup that has leveraged smart sensors and artificial intelligence to develop its connected inhaler and app suite Respiro — are looking to integrate novel technologies into medication packaging to better address the challenges of medication adherence. Following an unspecified investment in the...
By Dave Muoio 03:39 pmFebruary 12, 2018
Data from a recent analysis suggest that a substantial number of popular health apps have major privacy and security shortcomings, with many not following standard practices and upcoming European Union data safety regulations. The study, which examined a selection of 20 apps from the top 1080 of the “Medical” and “Health and Fitness” sections of the Google Play store, identified a number of minor...
By Dave Muoio 11:32 amFebruary 12, 2018
HealthifyMe, an Indian company offering a weight loss and fitness app that features an artificial intelligence-powered assistant, has raised $12 million in Series B funding. The round was led by Sistema Asia Fund, with Samsung NEXT, Atlas Asset Management, Dream Incubator, and others supporting the company for the first time. Returning investors IDG Ventures India, Inventus Capital, Blume...